Ibuprofen Jnx

Ibuprofen, the active ingredient in Ibuprofen Jnx, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as a standard oral tablet for oral use. It treats pain, fever, inflammation and arthritis in adults and children as appropriate.

GNH USA supplies Ibuprofen Jnx as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution. Customers benefit from consistent product availability, regulatory support and responsive technical assistance throughout.

Ibuprofen is an NSAID that reduces pain, fever and inflammation across several common conditions. - Pain: Provides analgesic relief by decreasing pain signaling. - Fever: Lowers elevated body temperature by acting on the hypothalamic set point. - Inflammation: Diminishes swelling and redness through inhibition of inflammatory mediators. - Arthritis: Alleviates joint pain and stiffness associated with osteoarthritis and rheumatoid arthritis.

Adverse reactions to ibuprofen may range from mild and transient to serious, though serious events are uncommon.

Common Side Effects: - Gastrointestinal discomfort - Headache - Dizziness - Rash

Serious or Rare Side Effects: - Gastrointestinal bleeding - Severe allergic reactions (anaphylaxis) - Renal impairment

When using ibuprofen, certain precautions help minimize risks and ensure safe therapy. - Assess renal function: evaluate baseline kidney status before initiating therapy. - Monitor gastrointestinal health: use with food or antacids in patients with ulcer risk. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Limit use in cardiovascular disease: weigh benefits against thrombotic risk. - Use lowest effective dose for shortest duration: reduce exposure to adverse effects. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Ibuprofen can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Selective COX‑2 inhibitors: additive renal toxicity. - High‑dose aspirin: enhanced gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in antihypertensive effect. - Lithium: increased serum lithium levels. - Methotrexate: reduced renal clearance leading to toxicity.